• Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    Search 
    •   QMRO Home
    • Barts Cancer Institute
    • Search
    •   QMRO Home
    • Barts Cancer Institute
    • Search
    ‌
    ‌

    Browse

    All of QMROCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CommunityBy Issue DateAuthorsTitlesSubjects
    ‌
    ‌

    Administrators only

    Login
    ‌
    ‌

    Discover

    AuthorManchanda, R (14)Menon, U (9)Jacobs, I (3)Antoniou, AC (2)Drapkin, R (2)Gessler, S (2)Kalsi, J (2)Legood, R (2)Pearce, L (2)Avril, S (1)... View MoreSubjectFemale (16)Humans (16)
    Ovarian Neoplasms (16)
    Genetic Predisposition to Disease (4)Middle Aged (4)Risk Assessment (4)Salpingectomy (4)Early Detection of Cancer (3)Fallopian Tube Neoplasms (3)Genes, BRCA1 (3)... View MoreDate Issued2022 (1)2019 (3)2018 (2)2017 (2)2016 (3)2015 (2)2013 (1)2012 (2)
    ‌
    ‌

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Search

    Show Advanced FiltersHide Advanced Filters

    Filters

    Use filters to refine the search results.

    Now showing items 1-10 of 16

    • Sort Options:
    • Relevance
    • Title Asc
    • Title Desc
    • Issue Date Asc
    • Issue Date Desc
    • Results Per Page:
    • 5
    • 10
    • 20
    • 40
    • 60
    • 80
    • 100
    Thumbnail

    Opportunistic bilateral salpingectomy (OBS) for the prevention of ovarian cancer should be offered in the context of a clinical trial: FOR: There is lack of clarity on a number of key issues. 

    Manchanda, R; Menon, U (2016-02)
    Thumbnail

    Impact of a decision aid about stratified ovarian cancer risk-management on women's knowledge and intentions: a randomised online experimental survey study. 

    Meisel, SF; Freeman, M; Waller, J; Fraser, L; Gessler, S; Jacobs, I; Kalsi, J; Manchanda, R; Rahman, B; Side, L;... (2017-11-16)
    BACKGROUND: Risk stratification using genetic and other types of personal information could improve current best available approaches to ovarian cancer risk reduction, improving identification of women at increased risk ...
    Thumbnail

    A risk prediction algorithm for ovarian cancer incorporating BRCA1, BRCA2, common alleles and other familial effects. 

    Jervis, S; Song, H; Lee, A; Dicks, E; Harrington, P; Baynes, C; Manchanda, R; Easton, DF; Jacobs, I; Pharoah, PPD;... (2015-07)
    BACKGROUND: Although BRCA1 and BRCA2 mutations account for only ∼27% of the familial aggregation of ovarian cancer (OvC), no OvC risk prediction model currently exists that considers the effects of BRCA1, BRCA2 and other ...
    Thumbnail

    Importance of serial CA125 measurements over an absolute cut-off value for the detection of asymptomatic ovarian cancer in high-risk patients. 

    Dilley, J; Manchanda, R; Johnson, M; Rosenthal, AN; Gessler, S; Menon, U (2016-05)
    Thumbnail

    The role of peritoneal cytology at risk-reducing salpingo-oophorectomy (RRSO) in women at increased risk of familial ovarian/tubal cancer. 

    Manchanda, R; Drapkin, R; Jacobs, I; Menon, U (2012-02)
    Thumbnail

    Opportunistic salpingectomy for prevention of ovarian cancer. 

    Manchanda, R (2017-05)
    Thumbnail

    Defining the risk threshold for risk reducing salpingo-oophorectomy for ovarian cancer prevention in low risk postmenopausal women. 

    Manchanda, R; Legood, R; Pearce, L; Menon, U (2015-12)
    OBJECTIVE: To define risk thresholds for cost-effectiveness of risk-reducing salpingo-oophorectomy (RRSO) for ovarian cancer (OC) prevention in low/intermediate risk postmenopausal women. METHODS: A decision-analytic model ...
    Thumbnail

    There is a need for routine peritoneal cytology at RRSO. 

    Manchanda, R; Drapkin, R; Menon, U (2013-01)
    Thumbnail

    Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data. 

    Cohen, PA; Powell, A; Böhm, S; Gilks, CB; Stewart, CJR; Meniawy, TM; Bulsara, M; Avril, S; Brockbank, EC; Bosse, T;... (2019-08)
    OBJECTIVE: There is a need to develop and validate biomarkers for treatment response and survival in tubo-ovarian high-grade serous carcinoma (HGSC). The chemotherapy response score (CRS) stratifies patients into ...
    Thumbnail

    A 3D tumor microenvironment regulates cell proliferation, peritoneal growth and expression patterns. 

    Loessner, D; Rockstroh, A; Shokoohmand, A; Holzapfel, BM; Wagner, F; Baldwin, J; Boxberg, M; Schmalfeldt, B; Lengyel, E; Clements, JA;... (2019-01)
    Peritoneal invasion through the mesothelial cell layer is a hallmark of ovarian cancer metastasis. Using tissue engineering technologies, we recreated an ovarian tumor microenvironment replicating this aspect of disease ...
    • 1
    • 2
    Twitter iconFollow QMUL on Twitter
    Twitter iconFollow QM Research
    Online on twitter
    Facebook iconLike us on Facebook
    • Site Map
    • Privacy and cookies
    • Disclaimer
    • Accessibility
    • Contacts
    • Intranet
    • Current students

    Modern Slavery Statement

    Queen Mary University of London
    Mile End Road
    London E1 4NS
    Tel: +44 (0)20 7882 5555

    © Queen Mary University of London.